No Picture
News

Locanabio Announces $100 Million Series B Financing to Advance Portfolio of Novel RNA-Targeted Gene Therapies for Neurodegenerative, Neuromuscular and Retinal Diseases

Financing led by Vida Ventures LLC with participation from RA Capital Management, Invus, Acuta Capital Partners, an investment fund associated with SVB Leerink, ARCH Venture Partners, Temasek, Lightstone Ventures, UCB Ventures and GV.Funding supports p… […]

No Picture
News

Qualigen Therapeutics Announces Board Member Amy Broidrick as EVP, Chief Strategy Officer and Names Sidney Emery, Jr. to its Board

– Amy Broidrick, a strategic and marketing executive with over 25 years of experience in biopharma companies- Sidney Emery, Jr., a senior executive with 50 years of leadership and business experience

CARLSBAD, Calif., Dec. 8, 2020 /PRNewswire/ — Qua… […]